Paper41920259
Ginsenoside Rg2 Targeting PDHE1 α to Improve High Glucose-Induced Hippocampal Neuronal Damage Based on CETSA Experiment.
Zhu LL and 4 others. Chin J Integr Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Ginsenoside Rg2 Targeting PDHE1 α to Improve High Glucose-Induced Hippocampal Neuronal Damage Based on CETSA Experiment. Papers, record 41920259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41920259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ginsenoside Rg2 Targeting PDHE1 α to Improve High Glucose-Induced Hippocampal Neuronal Damage Based on CETSA Experiment.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ginsenosides | Major topic |
| Hippocampus | Major topic |
| Neurons | Major topic |
| Glucose | Major topic |
| Pyruvate Dehydrogenase (Lipoamide) | Major topic |
| Animals | |
| Mice | |
| Cell Line | |
| Molecular Docking Simulation | |
| Reactive Oxygen Species | |
| Energy Metabolism | |
| Protein Binding |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38324697 | Dimerization of a 5-kDa domain defines the architecture of the 5-MDa gammaproteobacterial pyruvate dehydrogenase complex. | Sci Adv | 2024 | https://conductscience.org/library/papers/38324697 | PubMed |
| 2 | 36756776 | The Role of Pyruvate Metabolism in Mitochondrial Quality Control and Inflammation. | Mol Cells | 2023 | https://conductscience.org/library/papers/36756776 | PubMed |
| 3 | 35870376 | Evaluating the effects of mitochondrial autophagy flux on ginsenoside Rg2 for delaying D-galactose induced brain aging in mice. | Phytomedicine | 2022 | https://conductscience.org/library/papers/35870376 | PubMed |
| 4 | 31857574 | Mitochondrial dysfunction and oxidative stress in heart disease. | Exp Mol Med | 2019 | https://conductscience.org/library/papers/31857574 | PubMed |
| 5 | 32628351 | Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases. | J Diabetes Investig | 2021 | https://conductscience.org/library/papers/32628351 | PubMed |
| 6 | 37805189 | Ginsenoside Rg2 alleviates neurovascular damage in 3xTg-AD mice with Alzheimer's disease through the MAPK-ERK pathway. | J Chem Neuroanat | 2023 | https://conductscience.org/library/papers/37805189 | PubMed |
| 7 | 33382985 | Increased demand for NAD+ relative to ATP drives aerobic glycolysis. | Mol Cell | 2021 | https://conductscience.org/library/papers/33382985 | PubMed |
| 8 | 34270001 | Ginsenoside Rg2 Ameliorates Brain Injury After Intracerebral Hemorrhage in a Rat Model of Preeclampsia. | Reprod Sci | 2021 | https://conductscience.org/library/papers/34270001 | PubMed |
| 9 | 37750289 | Scutellarin Rescued Mitochondrial Damage through Ameliorating Mitochondrial Glucose Oxidation via the Pdk-Pdc Axis. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37750289 | PubMed |
| 10 | 26942671 | Mitochondria and Cancer. | Mol Cell | 2016 | https://conductscience.org/library/papers/26942671 | PubMed |
| 11 | 36863425 | The pyruvate dehydrogenase complex: Life's essential, vulnerable and druggable energy homeostat. | Mitochondrion | 2023 | https://conductscience.org/library/papers/36863425 | PubMed |
| 12 | 37355054 | Human peroxisomal NAD+/NADH homeostasis is regulated by two independent NAD(H) shuttle systems. | Free Radic Biol Med | 2023 | https://conductscience.org/library/papers/37355054 | PubMed |
| 13 | 40515882 | Pseudolaric Acid B Alleviates Non-alcoholic Fatty Liver Disease by Targeting PPARα to Regulate Lipid Metabolism and Promote Mitochondrial Biogenesis. | Chin J Integr Med | 2025 | https://conductscience.org/library/papers/40515882 | PubMed |
| 14 | 38195040 | Rare ginsenosides: A unique perspective of ginseng research. | J Adv Res | 2024 | https://conductscience.org/library/papers/38195040 | PubMed |
| 15 | 30245009 | Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals. | Cell | 2018 | https://conductscience.org/library/papers/30245009 | PubMed |
| 16 | 38301426 | Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities. | Bioorg Chem | 2024 | https://conductscience.org/library/papers/38301426 | PubMed |
| 17 | 39374880 | Hippocampal PDHA1 gene knockout inhibits the Warburg effect leading to cognitive dysfunction and attenuates the beneficial effects of ZiBuPiYin recipe on cognition. | J Ethnopharmacol | 2025 | https://conductscience.org/library/papers/39374880 | PubMed |
| 18 | 32181656 | Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1. | J Agric Food Chem | 2020 | https://conductscience.org/library/papers/32181656 | PubMed |
| 19 | 36900592 | Ginsenoside Rg2 Promotes the Proliferation and Stemness Maintenance of Porcine Mesenchymal Stem Cells through Autophagy Induction. | Foods | 2023 | https://conductscience.org/library/papers/36900592 | PubMed |
| 20 | 35809766 | Chip-DSF: A rapid screening strategy for drug protein targets. | Pharmacol Res | 2022 | https://conductscience.org/library/papers/35809766 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42775142 | Panax-derived ginsenosides in diabetes-associated cognitive dysfunction: mechanistic evidence and translational barriers. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42775142 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41920259
GET https://conductscience.org/api/papers/v1/41920259/references?page=2